Australia's Nova Eye Medical hits over 5-months low as loss widens
** Shares of Nova Eye Medical Ltd EYE.AX fall as much as
16.7% to A$0.20, their lowest level since March 20
** Medical technology co posts FY loss after tax of A$15.3
mln ($9.83 mln) vs A$7.5 mln loss a year ago
** Co posts FY revenues from continuing operations up 27% to
A$17.0 mln
** Co sees biggest intraday fall since April 5
** Shares of co are down 14.3% YTD as of last close
($1 = 1.5559 Australian dollars)
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment